Status:

COMPLETED

Early Endoscopic Indicators for OACs After Lung Transplantation: Development of a Novel Mucosal Healing Score

Lead Sponsor:

Thomas Fuehner

Conditions:

Airway Complication Which Require Any Intervention

Eligibility:

All Genders

18-80 years

Brief Summary

Airway complications are a significant cause of morbidity after lung transplantation (LTx). Bronchoscopic evaluation may help to identify risk factors for requiring interventions later.

Detailed Description

The investigators evaluated lung transplant recipients prospectively. Adult patients surviving 90 day after LTx will be included. The investigators propose a classification of airway healing based on ...

Eligibility Criteria

Inclusion

  • 3 month survivor after LTx
  • no OAC

Exclusion

  • \-

Key Trial Info

Start Date :

January 1 2007

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

August 1 2009

Estimated Enrollment :

180 Patients enrolled

Trial Details

Trial ID

NCT00940147

Start Date

January 1 2007

End Date

August 1 2009

Last Update

June 6 2013

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Hannover Medical School

Hanover, Germany, 30625